Exosomes based strategies for brain drug delivery

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Neuroscience

Background:

• Exosomes are nanoscale vesicles involved in intercellular communication.
• They possess natural drug delivery properties, including biocompatibility and ability to cross physiological barriers like the blood-brain barrier (BBB).
• These characteristics make them promising for therapeutic and diagnostic applications in various diseases.

Purpose of the Study:

• To highlight recent advancements in exosome-based drug delivery for neurodegenerative diseases and brain cancer.
• To summarize the challenges and future prospects for the clinical translation of exosome therapeutics.

Main Methods:

• Review of current literature on exosome-based drug delivery systems.
• Analysis of exosome properties relevant to drug delivery across the BBB.
• Identification of obstacles and future research directions for clinical application.

Main Results:

• Exosomes demonstrate efficient drug delivery, high biocompatibility, and ability to traverse the BBB.
• Exosome-based strategies are being developed for treating neurodegenerative diseases and brain cancers.
• Several challenges remain for the widespread clinical translation of these therapies.

Conclusions:

• Exosomes represent a viable nanotechnology for targeted drug delivery to the brain.
• Overcoming current obstacles is crucial for realizing the full therapeutic potential of exosomes in treating brain disorders.
• Continued research and development are essential for exosome-based clinical applications.